One barrier to Alzheimer’s diagnoses could crumble with Pitt’s discovery of a blood biomarker
Emily Largent of the Perelman School of Medicine hopes that blood-based tests will lower two long-standing barriers to the uptake of Alzheimer’s biomarker testing: high cost and high patient burden.
・ From Pittsburgh Post-Gazette